PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.87%
Net income growth under 50% of AVGO's 136.84%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
1.79%
D&A growth well above AVGO's 2.56%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
36.36%
Deferred tax of 36.36% while AVGO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
4.26%
Less SBC growth vs. AVGO's 20.00%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-129.33%
Negative yoy working capital usage while AVGO is 60.78%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
25.10%
AR growth while AVGO is negative at -170.59%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
1.35%
Some inventory rise while AVGO is negative at -200.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-233.33%
Both negative yoy AP, with AVGO at -60.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-97.81%
Negative yoy usage while AVGO is 202.86%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
No Data
No Data available this quarter, please select a different quarter.
-20.85%
Negative yoy CFO while AVGO is 180.49%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-29.22%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-2.00%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
43.04%
Liquidation growth of 43.04% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
500.00%
We have mild expansions while AVGO is negative at -100.00%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment similar to AVGO's 99.73%. Walter Schloss sees parallel liability management or similar free cash flow availability.
No Data
No Data available this quarter, please select a different quarter.
-48.81%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.